Oral intake of Lactobacillus rhamnosus M21 enhances the survival rate of mice lethally infected with influenza virus

Journal of Microbiology, Immunology and Infection

Volumn 49, Issue 1, 2016, Pages 16-23

  Song, Jeong Ah ^a,c   Kim, Hee Joo ^a   Hong, Seong Keun ^a   Lee, Dong Hoon ^a   Lee, Sang Won ^a   Song, Chang Seon ^a   Kim, Ki Taek ^b   Choi, In Soo ^a   Lee, Joong Bok ^a   Park, Seung Yong ^a  

^a Konkuk University   (South Korea)

^b M21 Company Limited   (South Korea)

^c Korea Institute of Toxicology   (South Korea)

Author keywords

Cytokines; Immunoglobulin A; Influenza; Lung infection; Probiotics

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; INFECTION PREVENTION; INFLAMMATORY CELL; INFLUENZA; INFLUENZA A VIRUS (H1N1); LACTOBACILLUS RHAMNOSUS; LETHAL DOSE; LUNG FIBROSIS; LUNG INJURY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; MUCOSAL IMMUNITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMONIA; SURVIVAL RATE; VIRUS ENTRY; ANIMAL; BAGG ALBINO MOUSE; DISEASE RESISTANCE; IMMUNOLOGY; LUNG; ORAL DRUG ADMINISTRATION; ORTHOMYXOVIRIDAE INFECTIONS; PATHOLOGY;

ADMINISTRATION, ORAL; ANIMALS; CYTOKINES; DISEASE RESISTANCE; FEMALE; IMMUNOGLOBULIN A, SECRETORY; LACTOBACILLUS RHAMNOSUS; LUNG; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PROBIOTICS; SURVIVAL RATE;

EID: 84958061076     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.07.011     Document Type: Article

References (30)

1. Osterholm M.T. Preparing for the next pandemic. N Engl J Med 2005, 352:1839-1842.
2. Palese P. Influenza: old and new threats. Nat Med 2004, 10:S82-S87.
3. Apisarnthanarak A., Kitphati R., Thongphubeth K., Patoomanunt P., Anthanont P., Auwanit W., et al. Atypical avian influenza (H5N1). Emerg Infect Dis 2004, 10:1321-1324.
4. Rimmelzwaan G.F., van Riel D., Baars M., Bestebroer T.M., van Amerongen G., Fouchier R.A., et al. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol 2006, 168:176-183.
5. Seo S.U., Lee K.H., Byun Y.H., Kweon M.N., Seong B.L. Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine. Vaccine 2007, 47:8067-8076.
6. Loo Y.M., Gale M. Influenza: fatal immunity and the 1918 virus. Nature 2007, 445:267-268.
7. Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007, 25:6852-6862.
8. Gibson G.R., Fuller R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J Nutr 2000, 130:391S-395S.
9. Hori T., Kiyoshima J., Shida K., Yasui H. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin Diagn Lab Immunol 2002, 9:105-108.
10. Yasui H., Kiyoshima J., Hori T., Shida K. Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064. Clin Diagn Lab Immunol 1999, 6:186-192.
11. Yasui H., Kiyoshima J., Hori T. Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn Lab Immunol 2004, 11:675-679.
12. Youn H.N., Lee D.H., Lee Y.N., Park J.K., Yuk S.S., Yang S.Y., et al. Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice. Antiviral Res 2012, 93:138-143.
13. Lee Y.N., Youn H.N., Kwon J.H., Lee D.H., Park J.K., Yuk S.S., et al. Sublingual administration of Lactobacillus rhamnosus affects respiratory immune responses and facilitates protection against influenza virus infection in mice. Antiviral Res 2013, 98:284-290.
14. Monteiro J.M., Harvey C., Trinchieri G. Role of interleukin-12 in primary influenza virus infection. J Virol 1998, 72:4825-4831.
15. Perdigón G., Vintiñi E., Alvarez S., Medina M., Medici M. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J Dairy Sci 1999, 82:1108-1114.
16. Budd A., Alleva L., Alsharifi M., Koskinen A., Smythe V., Müllbacher A., et al. Increased survival after gemfibrozil treatment of severe mouse influenza. Antimicrob Agents Chemother 2007, 51:2965-2968.
17. Karlström A., Boyd K.L., English B.K., McCullers J.A. Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza. J Infect Dis 2009, 199:311-319.
18. Schmitz N., Kurrer M., Bachmann M.F., Kopf M. Interleukin-is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol 2005, 79:6441-6448.
19. Kozak W., Zheng H., Conn C.A., Soszynski D., van der Ploeg L.H., Kluger M.J. Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-beta-deficient mice. Am J Physiol 1995, 269:R969-R977.
20. Kishimoto T., Akira S., Taga T. Interleukin-and its receptor: a paradigm for cytokines. Science 1992, 258:593-597.
21. Kozak W., Poli V., Soszynski D., Conn C.A., Leon L.R., Kluger M.J. Sickness behavior in mice deficient in interleukin-during turpentine abscess and influenza pneumonitis. Am J Physiol 1997, 272:R621-R630.
22. Longhi M.P., Wright K., Lauder S.N., Nowell M.A., Jones G.W., Godkin A.J., et al. Interleukin-is crucial for recall of influenza-specific memory CD4 T cells. PLoS Pathog 2008, 4:e1000006.
23. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med 1994, 180:1273-1282.
24. Mohamadzadeh M., Olson S., Kalina W.V., Ruthel G., Demmin G.L., Warfield K.L., et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA 2005, 102:2880-2885.
25. Trinchieri G., Scott P. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res Immunol 1995, 146:423-431.
26. Arulanandam B.P., O'Toole M., Metzger D.W. Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity. J Infect Dis 1999, 180:940-949.
27. Renegar K.B., Small P.A. Passive transfer of local immunity to influenza virus infection by IgA antibody. J Immunol 1991, 146:1972-1978.
28. Dugas B., Mercenier A., Lenoir-Wijnkoop I., Arnaud C., Dugas N., Postaire E. Immunity and probiotics. Immunol Today 1999, 20:387-390.
29. Mazanec M.B., Coudret C.L., Fletcher D.R. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 1995, 69:1339-1343.
30. Kajander K., Hatakka K., Poussa T., Färkkilä M., Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 2005, 22:387-394.